IL3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Integra Lifesciences Holdings Corp

Watchlist Manager

Watchlist

Price: 16.3 EUR -1.21% Market Closed

Market Cap: €1.3B

I	Integra Lifesciences Holdings Corp F:IL3	US
D	Dermapharm Holding SE XMUN:DMP	DE
S	Sumitomo Realty & Development Co Ltd DUS:RL2	JP
S	Sompo Holdings Inc XMUN:ANK	JP
	Yangtze Optical Fibre and Cable Joint Stock Ltd Co F:1YO	CN
I	Invincible Investment Corp F:8JF	JP
	Halliburton Co NYSE:HAL	US
R	Realty Income Corp F:RY6	US

Profitability Summary

Integra Lifesciences Holdings Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

57%

Strong 3Y Average Gross Margin

60%

Declining Gross Margin

63% > 57%

Healthy Operating Margin

11%

Sustainable 3Y Average Operating Margin

13%

Declining Operating Margin

18% > 11%

Negative Net Margin

-30%

Negative 3Y Average Net Margin

-8%

Declining Net Margin

8% > -30%

Negative Free Cash Flow Margin

-1%

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

10% > -1%

Negative ROE

-39%

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.